Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 134,360 shares at $34.04 ($4.6M) on 2021-08-11, disclosed to the SEC on 2021-08-12.
Open-market sale of $4.6M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.76 | 17,905 | $622K | 13.5% |
| 2 | $34.76 | 17,905 | $622K | 13.5% |
| 3 | $35.54 | 2,600 | $92K | 2.0% |
| 4 | $34.04 | 34,439 | $1.2M | 25.4% |
| 5 | $34.04 | 34,439 | $1.2M | 25.4% |
| 6 | $34.35 | 11,565 |
| $397K |
| 8.6% |
| 7 | $34.35 | 11,565 | $397K | 8.6% |
| 8 | $34.83 | 1,971 | $69K | 1.5% |
| 9 | $34.83 | 1,971 | $69K | 1.5% |
| Total | $34.34 avg | 134,360 | $4.6M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |